Our group uses novel gene engineering strategies to decode key genetic programs that we can target to rewire immune cells into effective cancer treatments.
Using single cell genomics and tissue imaging, we study the cellular interactions that shape immune responses in human tumors in order to harness the immune system in the fight against cancer.
The Gordan lab combines chemical biology with cancer systems biology strategies to identify new therapeutic targets and drug combinations for GI cancers.
We are designing synthetic receptors and editing the T cell’s genome to better understand T cells function within the tumor microenvironment and ultimately design safe and efficient adoptive T cell therapies
Dr. Jennifer Y. Chen’s research program focuses on the development of novel antifibrotic therapies and biomarkers for patients with chronic liver disease.